BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/3/2014 10:14:00 AM | Browse: 810 | Download: 924
 |
Received |
|
2013-10-01 20:42 |
 |
Peer-Review Started |
|
2013-10-01 21:58 |
 |
To Make the First Decision |
|
2013-10-14 21:19 |
 |
Return for Revision |
|
2013-10-15 20:04 |
 |
Revised |
|
2013-11-12 18:27 |
 |
Second Decision |
|
2013-11-29 10:56 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2013-11-29 23:57 |
 |
Articles in Press |
|
|
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-01-10 16:16 |
 |
Publish the Manuscript Online |
|
2014-02-17 14:01 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival
|
Manuscript Source |
Invited Manuscript |
All Author List |
Luciana Kikuchi, Marcos Menezes, Aline L Chagas, Claudia M Tani, Regiane SSM Alencar, Marcio A Diniz, Venâncio AF Alves, Luiz Augusto Carneiro D’Albuquerque and Flair José Carrilho |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Alves de Queiroz Family Fund for Research |
|
|
Corresponding Author |
Luciana Kikuchi, MD, São Paulo Clínicas Liver Cancer Group, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Department of Gastroenterology, University of São Paulo School of Medicine, 255 Arnaldo Avenue, São Paulo 01246000, Brazil. lucianakikuchi@usp.br
|
Key Words |
Hepatocellular carcinoma; Radiofrequency ablation; Overall survival; Disease-free survival |
Core Tip |
Radiofrequency ablation (RFA) is widely recognized as an effective therapy for early stage hepatocellular carcinoma (HCC) in patients who are not suitable candidates for surgical resection, such as those with decompensated liver function or portal hypertension. Reports from Brazil of clinical experience with RFA management of HCC are rare. This study evaluated 34 consecutive patients with early HCC treated with RFA at a single Brazilian hospital. RFA was efficacious for promoting local tumor control and positive outcome was related to preserved liver function. Careful evaluation of liver function may help to identify the best candidates for this procedure. |
Publish Date |
2014-02-17 14:01 |
Citation |
Kikuchi L, Menezes M, Chagas AL, Tani CM, Alencar RSSM, Diniz MA, Alves VAF, D’Albuquerque LAC, Carrilho FJ. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: Risk factors for survival. World J Gastroenterol 2014; 20(6): 1585-1593 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i6/1585.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i6.1585 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345